In a first study, we found that SSc sera not only significantly inhibited the proliferation, invasion, wound healing capacity, and capillary morphogenesis of normal human dermal lymphatic MVECs, but also led to a significant downregulation of both VEGFR-3/Flt-4 and NRP-2 [41]. The gene discussed is FLT4; the disease is systemic sclerosis.